Month: May 2022

Kiruna May 18, 2022 Norrlandsfonden will invest further MSEK 5.5 in a convertible debenture in Copperstone Resources AB (“Copperstone” or “the Company”). In accordance with the existing loan agreement in connection with fund raisings, Norrlandsfonden has the right, but not obligation, to invest in Copperstone. The credit facilities are agreed at Stibor 90 + 5 percent annually, with quarterly interest payments. Norrlandsfonden is entitled to convert parts of the, or the entire, amount until April 30, 2027. The conversion prices shall be 1.54 SEK/share, corresponding to a 40 percent premium from the volume weighted average of the recent directed equity issues at approximately 1.1 SEK per share. At full conversion of the debenture, Norrlandsfonden would receive 3,571,428 shares of Copperstone, corresponding to a dilution of 0.3%. “We are...

LANCASTER, Pa., May 17, 2022 (GLOBE NEWSWIRE) — Armstrong Flooring, Inc. (the “Company”) today announced that it has received approval from the U.S. Bankruptcy Court for the District of Delaware to access its consensual debtor-in-possession (“DIP”) financing totaling $24 million in net new money. This financing will provide the Company with the necessary liquidity to continue operating in the ordinary course as it pursues a swift, value-maximizing sale process. The DIP financing consists of an asset-based revolving credit facility and a term loan facility (together, the “DIP Facilities”). The DIP Facilities are being provided by the Company’s pre-petition lenders, which include Bank of America, N.A. (“BANA”), other institutional lenders and affiliates of Pathlight Capital LP (“Pathlight”). BANA...

MALVERN, Pa., May 17, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX) (the “Company”), a pharmaceutical company focused on innovative products for acute care settings, today announced that it has entered into a definitive agreement with certain institutional investors for the issuance and sale of 1,646,091 shares of its common stock, at a purchase price of $1.215 per share, in a registered direct offering priced at-the-market under Nasdaq rules. The Company also agreed to issue to the investors, in a concurrent private placement, unregistered warrants to purchase up to 1,646.091 shares of its common stock. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The warrants have an exercise price of $1.09 per share, will be exercisable immediately upon issuance and will expire five years from...

VANCOUVER, British Columbia, May 17, 2022 (GLOBE NEWSWIRE) — Hunter Technology Corp. (TSX- V: HOC; OTCQB: HOILF; WKN: A2QEYH, FSE: RWPM, ISIN: CA4457371090) (“Hunter” or the “Company”) is providing this status update in accordance with its obligations under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), which require the Company to provide bi-weekly updates until such time as the Company is current with its filing obligations under Canadian securities laws. As previously announced, the Company is subject to a management cease trade order (“MCTO“) issued by the British Columbia Securities Commission dated May 3, 2022. The MCTO prohibits the directors and executive officers of the Company from trading in or acquiring securities of the Company until two full business days after the Company...

SAN ANTONIO, May 17, 2022 (GLOBE NEWSWIRE) — Usio, Inc: (Nasdaq:USIO), a leading FinTech integrated payment solutions provider, today announced that management will participate in the H.C. Wainwright Global Investment Conference being held May 23 – 26, 2022 in Miami, Florida. Louis Hoch, Chief Executive Officer; Greg Carter, Senior Vice President, Payment Facilitation; and Houston Frost, Senior Vice President, Prepaid Services, will be representing the Company. The Company’s on-demand audio webcast will be held on May 24, 2022, at 1:30 pm ET, and will be accessible in the investor relations section of Usio’s website at www.usio.com. Investors interested in arranging a meeting with the Company’s management during the conference should contact meetings@hcwo.com or email joeh@gregoryfca.com. About Usio, Inc. Usio, Inc. (Nasdaq:USIO),...

Activities Highlighting Profound’s Ground-Breaking Technology Included a Semi-Live TULSA Procedure Performed by UT Southwestern’s Dr. Kenneth A. Goldberg During Meeting’s Plenary Session TORONTO, May 17, 2022 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that multiple clinical presentations and product demonstrations performed at the American Urological Association’s (“AUA”) 2022 Annual Meeting, which took place from May 13 – 16 in New Orleans, highlighted the ability of TULSA-PRO® to effectively and safely ablate physician-prescribed prostate tissue in an unrivaled variety of patients with prostate cancer and benign...